Germany

On the regulatory side, the Federal Institutefor Drugs and Medical Devices is the authoritycompetent to grant a national marketingauthorisation for pharmaceuticals marketedin Germany, based on the Medicinal ProductsAct. Within the framework of the authorisationproceedings, the institute reviewspharmaceutical trademarks in accordance withArticle 8 of the act.